SCHEMBL4271073

SCHEMBL4271073

OCc1cccc(-c2cccc(O)c2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 10/20 0.52
HSD17B2 P37059 9/20 0.52
METAP2 P50579 1/20 0.49
HSD17B14 Q9BPX1 2/20 0.46
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
PIK3R1 P27986 1/20 0.44
PIK3CA P42336 1/20 0.44
MAP4K4 O95819 1/20 0.43
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
POLB P06746 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30862097 0.82 HSD17B1 (0.66) HSD17B1HSD17B2METAP2HSD17B14CYP3A4
SCHEMBL27673847 0.81 MAPT (0.67) HSD17B1HSD17B2ESR1ESR2POLB
SCHEMBL2953474 0.81 MEN1 (0.60) POLBHSD17B10ALDH1A1MAPTHPGD
SCHEMBL29897575 0.81 KMO (0.48) MAP4K4ESR2MAPTTRPV3SMN1; SMN2
SCHEMBL17595532 0.81 KMO (0.48) MAP4K4ESR2MAPTTRPV3SMN1; SMN2
SCHEMBL4271071 0.81 TRPV3 (0.41) TRPV3RAB9A
SCHEMBL4591178 0.81 CNR2 (0.48) MAP4K4TRPV3
SCHEMBL16588099 0.78 CCR1 (0.48) POLBHSD17B10ALDH1A1MAPTHPGD
SCHEMBL9145225 0.76 CCR1 (0.46) POLBHSD17B10ALDH1A1MAPTHPGD
SCHEMBL23525615 0.74 CCR1 (0.56) HSD17B1HSD17B2METAP2HSD17B14CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094662-B1 POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS ASTELLAS PHARMA INC (JP) 2012-04-11 EP disclosed
CN-101636386-A Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents ASTELLAS PHARMA INC 2010-01-27 CN disclosed
EP-2094662-A1 POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS Astellas Pharma Inc. (JP) 2009-09-02 EP disclosed
WO-2008072784-A1 POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS ASTELLAS PHARMA INC. (JP) 2008-06-19 WO disclosed